Nymox Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NYMX and other ETFs, options, and stocks.

About NYMX

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. 

CEO
Paul Averback
CEOPaul Averback
Employees
3
Employees3
Headquarters
Nassau, New Providence
HeadquartersNassau, New Providence
Founded
1995
Founded1995
Employees
3
Employees3

NYMX Key Statistics

Market cap
28.83M
Market cap28.83M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
51.42K
Average volume51.42K
High today
$0.32
High today$0.32
Low today
$0.3068
Low today$0.3068
Open price
$0.32
Open price$0.32
Volume
15.27K
Volume15.27K
52 Week high
$2.10
52 Week high$2.10
52 Week low
$0.185
52 Week low$0.185

NYMX Earnings

-$0.06
-$0.04
-$0.01
$0.01
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
-$0.02 per share
Actual-$0.02 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.